Financials data is unavailable for this security.
View more
Year on year Banvit Bandirma Vitaminli Yem Sanayi AS grew revenues 5.18% from 20.27bn to 21.32bn. In addition the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as a percent of sales). The company reported positive net income, improving from a loss of 982.67m to a profit of 951.97m.
Gross margin | 17.49% |
---|---|
Net profit margin | 10.84% |
Operating margin | 9.62% |
Return on assets | 26.50% |
---|---|
Return on equity | 62.93% |
Return on investment | 53.75% |
More ▼
Cash flow in TRYView more
In 2023, Banvit Bandirma Vitaminli Yem Sanayi AS increased its cash reserves by 46.82%, or 381.38m. The company earned 3.10bn from its operations for a Cash Flow Margin of 14.52%. In addition the company used 1.14bn on investing activities and also paid 1.20bn in financing cash flows.
Cash flow per share | 47.15 |
---|---|
Price/Cash flow per share | 7.26 |
Book value per share | 73.97 |
---|---|
Tangible book value per share | 73.25 |
More ▼
Balance sheet in TRYView more
Current ratio | 1.43 |
---|---|
Quick ratio | 1.01 |
Total debt/total equity | 0.2014 |
---|---|
Total debt/total capital | 0.1677 |
More ▼
Growth rates in TRY
Year on year, growth in earnings per share excluding extraordinary items increased 205.17%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years) | 65.33 |
---|---|
EPS (TTM) vs TTM 1 year ago | 452.81 |